Quote:
Originally Posted by Florence
|
I think its fair to say that if you
compare VM's share price with the NASDAQ (where VM is listed in the US) over a period of the last two/three months, its fair to say that its shares have largely been in line with the NASDAQ's overall performance.
Whether their shares will be affected by a confirmed implementation of Phorm or similar system is yet to be seen.